Home › Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab
 

Keywords :   


Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab

2014-09-17 14:30:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J., and MUMBAI, India WHITEHOUSE STATION, N.J., and MUMBAI, India--(BUSINESS WIRE)--Merck & Co., Inc., (NYSE:MRK), known as MSD outside the United States and Canada, and Sun Pharmaceutical Industries Ltd. Language: English Contact: MerckMedia:Ian McConnell, 908- 423-3046Investor:Justin Holko, 908-423-5088orSun PharmaMedia:Frederick Castro, +91-22-66455964Investor:Nimish Desai, +91-22-66455717 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: 524715 Exchange: MUMBAI read more

Tags: for enter agreement sun

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »